Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Yasutaka Maeda"'
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 9, Pp 1081-1091 (2023)
ABSTRACT Aim/Introduction This study aimed to investigate the clinical utility of 3 Screen ICA ELISA in identifying immune‐mediated type 1 diabetes in Japanese subjects. Methods We compared the positivity of 3 Screen ICA were compared with autoanti
Externí odkaz:
https://doaj.org/article/8c48c5969689435892c2b3319eb69ae8
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 14, p 7618 (2024)
The 3 Screen ICA ELISA is a novel assay capable of simultaneously measuring autoantibodies to glutamic acid decarboxylase (GADA), insulinoma-associated antigen-2 (IA-2A), and zinc transporter 8 (ZnT8A), making it a valuable tool for screening type 1
Externí odkaz:
https://doaj.org/article/906d41aa07ba4dec943bcc5db519d9d0
Autor:
Kentaro Abe, Yasutaka Maeda, Chitose Matsuzaki, Hisashi Yokomizo, Tomoaki Inoue, Noriyuki Sonoda, Yoshihiro Ogawa, Toyoshi Inoguchi
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 11, Pp 2028-2035 (2021)
Abstract Aims/Introduction Diagnosis of diabetic peripheral neuropathy (DPN) depends on subjective findings, certain investigations for DPN risks have not been performed enough. Bilirubin protects against vascular complications by reducing oxidative
Externí odkaz:
https://doaj.org/article/118cc65d3a914a78a4171569cea73716
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 12, Pp 2101-2102 (2022)
Externí odkaz:
https://doaj.org/article/79877b42363743a09f96c3658ccf8ea3
Autor:
Tasuku Okui, Chinatsu Nojiri, Shinichiro Kimura, Kentaro Abe, Sayaka Maeno, Masae Minami, Yasutaka Maeda, Naoko Tajima, Tomoyuki Kawamura, Naoki Nakashima
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background No case definition of Type 1 diabetes (T1D) for the claims data has been proposed in Japan yet. This study aimed to evaluate the performance of candidate case definitions for T1D using Electronic health care records (EHR) and clai
Externí odkaz:
https://doaj.org/article/ba43cdda4b9d4f3db45f5da72173a528
Autor:
Erina Eto, Yasutaka Maeda, Noriyuki Sonoda, Naoki Nakashima, Kunihisa Kobayashi, Ryoichi Takayanagi, Yoshihiro Ogawa, Toyoshi Inoguchi
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0271179 (2022)
ObjectivePrevious reports have demonstrated the association of serum bilirubin levels with the progression of diabetic nephropathy. The objective of this study is to assess the association of basal bilirubin levels with progressive renal decline (PRD
Externí odkaz:
https://doaj.org/article/f6fd82c3763d4cdb979406216f112b36
Autor:
Yuichi Takashi, Yasutaka Maeda, Kyoko Toyokawa, Naoki Oda, Rie Yoshioka, Dan Sekiguchi, Masae Minami, Daiji Kawanami
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0274182 (2022)
Diabetic kidney disease (DKD) is a key determinant of morbidity and mortality in patients with type 1 diabetes (T1D). Identifying factors associated with early glomerular filtration rate (GFR) decline in T1D is important in prevention or early interv
Externí odkaz:
https://doaj.org/article/3e01d4e2c5064e8a84581c0270963dcd
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Introduction Type 1 diabetes (T1D) is associated with higher fracture risk. However, few studies have investigated the relationship between severe hypoglycemia and fracture risk in patients with T1D, and the results are controversial. Besides, none h
Externí odkaz:
https://doaj.org/article/89e579a960a44084b080a09f146490c2
Publikováno v:
Crystals, Vol 5, Iss 3, Pp 302-311 (2015)
Polymer/cholesteric liquid crystal (ChLC) nano-composites consisting of mesogenic monomers and LCs have nano-sized LC domains dispersed in an anisotropic polymer matrix. They exhibit characteristics not observed in conventional ChLCs, such as sub-mil
Externí odkaz:
https://doaj.org/article/68c886b8bf99495c8153ff9833ccdd31
Autor:
Ryuta Shiiyama, Yoshibumi Antoku, Masao Takemoto, Takuya Tsuchihashi, Atsushi Tanaka, Takahiro Mito, Hiroko Otsuka-Morisaki, Yasutaka Maeda
Publikováno v:
Internal Medicine
Background We previously reported that, among asymptomatic patients with type 2 diabetes mellitus (T2DM) without a history of cardiovascular disease (CVD), up to 19% of the patients with myocardial ischemia were detected by annual cardiovascular scre